Philip Hartjen
Dr. rer. nat.
Philip Hartjen
  • Wissenschaftlicher Mitarbeiter


O48 , 4. Etage, Raumnummer 411
Deutsch (Muttersprache)



  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2009

Managing NF2-associated vestibular schwannomas in children and young adults: review of an institutional series regarding effects of surgery and bevacizumab on growth rates, tumor volume, and hearing quality
Gugel I, Zipfel J, Hartjen P, Kluwe L, Tatagiba M, Mautner V, Schuhmann M
CHILD NERV SYST. 2020 [Epub ahead of print].

A short-term plastic adherence incubation of the stromal vascular fraction leads to a predictable GMP-compliant cell-product
Born S, Dörfel M, Hartjen P, Haschemi Yekani , Luecke J, Meutsch J, Westphal J, Birkelbach M, Köhnke R, Smeets R, Krueger M
Bioimpacts. 2019;9(3):161-172.

The Influence of an Ultrasonic Cleaning Protocol for CAD/CAM Abutment Surfaces on Cell Viability and Inflammatory Response
Gehrke P, Smeets R, Gosau M, Friedrich R, Madani E, Duddeck D, Fischer C, Tebbel F, Sader R, Hartjen P
IN VIVO. 2019;33(3):689-698.

Cytocompatibility of Titanium, Zirconia and Modified PEEK after Surface Treatment Using UV Light or Non-Thermal Plasma
Guo L, Smeets R, Kluwe L, Hartjen P, Barbeck M, Cacaci C, Gosau M, Henningsen A
INT J MOL SCI. 2019;20(22):.

Improved In Vitro Test Procedure for Full Assessment of the Cytocompatibility of Degradable Magnesium Based on ISO 10993-5/-12
Jung O, Smeets R, Hartjen P, Schnettler R, Feyerabend F, Klein M, Wegner N, Walther F, Stangier D, Henningsen A, Rendenbach C, Heiland M, Barbeck M, Kopp A
INT J MOL SCI. 2019;20(2):.

Plasma Electrolytic Oxidation of Titanium Implant Surfaces: Microgroove-Structures Improve Cellular Adhesion and Viability
Hartjen P, Hoffmann A, Henningsen A, Barbeck M, Kopp A, Kluwe L, Precht C, Quatela O, Gaudin R, Heiland M, Friedrich R, Knipfer C, Grubeanu D, Smeets R, Jung O
IN VIVO. 2018;32(2):241-247.

Photofunctionalization and non-thermal plasma activation of titanium surfaces
Henningsen A, Smeets R, Hartjen P, Heinrich O, Heuberger R, Heiland M, Precht C, Cacaci C
CLIN ORAL INVEST. 2018;22(2):1045-1054.

Cytocompatibility of Direct Laser Interference-patterned Titanium Surfaces for Implants
Hartjen P, Nada O, Silva T, Precht C, Henningsen A, Holthaus M, Gulow N, Friedrich R, Hanken H, Heiland M, Zwahr C, Smeets R, Jung O
IN VIVO. 2017;31(5):849-854.

Biocompatibility and Osseointegration of Titanium Implants with a Silver-Doped Polysiloxane Coating: An In Vivo Pig Model
Smeets R, Precht C, Hahn M, Jung O, Hartjen P, Heiland M, Gröbe A, Holthaus M, Hanken H
INT J ORAL MAX IMPL. 2017;32(6):1338–1345.

Reduced CD161(+) MAIT cell frequencies in HCV and HIV/HCV co-infection: Is the liver the heart of the matter?
Eberhard J, Kummer S, Hartjen P, Hüfner A, Diedrich T, Degen O, Lohse A, Lunzen J, Schulze Zur Wiesch J
J HEPATOL. 2016;65(6):1261-1263.

Attachment, Viability and Adipodifferentiation of Pre-adipose Cells on Silk Scaffolds with and Without Co-expressed FGF-2 and VEGF.
Hanken H, Göhler F, Smeets R, Heiland M, Gröbe A, Friedrich R, Busch C, Blessmann M, Kluwe L, Hartjen P
IN VIVO. 2016;30(5):567-72.

PEO-generated Surfaces Support Attachment and Growth of Cells In Vitro with No Additional Benefit for Micro-roughness in Sa (0.2-4 μm)
Jung O, Smeets R, Kopp A, Porchetta D, Hiester P, Heiland M, Friedrich R, Precht C, Hanken H, Gröbe A, Hartjen P
IN VIVO. 2016;30(1):27-33.

Optimized in vitro procedure for assessing the cytocompatibility of magnesium-based biomaterials
Jung O, Smeets R, Porchetta D, Kopp A, Ptock C, Müller U, Heiland M, Schwade M, Behr B, Kröger N, Kluwe L, Hanken H, Hartjen P
ACTA BIOMATER. 2015;23:354-363.

CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression
Eberhard J, Hartjen P, Kummer S, Schmidt R, Bockhorn M, Lehmann C, Balagopal A, Hauber J, Lunzen J, Schulze zur Wiesch J
PLOS ONE. 2014;9(11):e111323.

Bone substitutes enhance osteogenic differentiation of mesenchymal stem cells in three-dimensional scaffolds
Hanken H, Alpers J, Böbel M, Wöltje M, Hartjen P, Friedrich R, Jung O, Rendenbach C, Gröbe A, Heiland M, Al-Dam A, Eichhorn W, Smeets R
IN VIVO. 2014;28(5):733-9.

Osteogenic differentiation of mesenchymal stem cells in fibrin-hydroxyapatite matrix in a 3-dimensional mesh scaffold
Jung O, Hanken H, Smeets R, Hartjen P, Friedrich R, Schwab B, Gröbe A, Heiland M, Al-Dam A, Eichhorn W, Sehner S, Kolk A, Wöltje M, Stein J
IN VIVO. 2014;28(4):477-82.

From bench to application: Current practices in tissue engineering and its realisation at maxillofacial units in Germany, Austria and Switzerland
Smeets R, El-Moawen A, Jung O, Hanken H, Hartjen P, Heiland M, Kansy K, Kloss F, Kolk A
J CRANIO MAXILL SURG. 2014;42(7):1128-1132.

Was können regenerative Materialien in der Zahnmedizin leisten – und wo sind die Grenzen?
Smeets R, Jung O, Hanken H, Hartjen P, Al-Dam A, Gröbe A, Heiland M, Gosau M, Rothamel D, Schlee M, Iglhaut G, Kolk A
DZZ - Deut Zahnärztl Z. 2014;69:708-721.

The NTPase/helicase domain of hepatitis C virus nonstructural protein 3 inhibits protein kinase C independently of its NTPase activity
Hartjen P, Höchst B, Heim D, von der Kammer H, Lucke J, Reinholz M, Baier A, Smeets R, Wege H, Borowski P, Schulze Zur Wiesch J
CELL MOL BIOL LETT. 2013;18(3):447-58.

Vγ2Vδ2 T cells are skewed toward a terminal differentiation phenotype in untreated HIV infection
Hartjen P, Meyer-Olson D, Lehmann C, Stellbrink H, van Lunzen J, Schulze zur Wiesch J
J INFECT DIS. 2013;208(1):180-2.

Highly significant antiviral activity of HIV-1 LTR-specific tre-recombinase in humanized mice
Hauber I, Hofmann-Sieber H, Chemnitz J, Dubrau D, Chusainow J, Stucka R, Hartjen P, Schambach A, Ziegler P, Hackmann K, Schröck E, Schumacher U, Lindner C, Grundhoff A, Baum C, Manz M, Buchholz F, Hauber J
PLOS PATHOG. 2013;9(9):e1003587.

Decreased frequency of CD73+CD8+ T cells of HIV-infected patients correlates with immune activation and T cell exhaustion
Tóth I, Le A, Hartjen P, Thomssen A, Matzat V, Lehmann C, Scheurich C, Beisel C, Busch C, Degen O, Lohse A, Eiermann T, Fätkenheuer G, Meyer-Olson D, Bockhorn M, Hauber J, Lunzen J, Schulze Zur Wiesch J
J LEUKOCYTE BIOL. 2013;94(4):551-61.

Assessment of the range of the HIV-1 infectivity enhancing effect of individual human semen specimen and the range of inhibition by EGCG.
Hartjen P, Frerk S, Hauber I, Matzat V, Thomssen A, Holstermann B, Hohenberg H, Schulze W, Schulze Zur Wiesch J, van Lunzen J
AIDS RES THER. 2012;9(1):2.

Expansion of HIV-specific T follicular helper cells in chronic HIV infection.
Lindqvist M, van Lunzen J, Soghoian D, Kuhl B, Ranasinghe S, Kranias G, Flanders M, Cutler S, Yudanin N, Muller M, Davis I, Farber D, Hartjen P, Haag F, Alter G, Schulze Zur Wiesch J, Streeck H
J CLIN INVEST. 2012;122(9):3271-3280.

Stereoselective synthesis of D- and L-carbocyclic nucleosides by enzymatically catalyzed kinetic resolution.
Mahler M, Reichardt B, Hartjen P, van Lunzen J, Meier C
CHEM-EUR J. 2012;18(35):11046-11062.

Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
Schulze Zur Wiesch J, Thomssen A, Hartjen P, Toth I, Lehmann C, Meyer-Olson D, Colberg K, Frerk S, Babikir D, Schmiedel S, Degen O, Mauss S, Rockstroh J, Staszewski S, Khaykin P, Strasak A, Lohse A, Fätkenheuer G, Hauber J, van Lunzen J
J VIROL. 2011;85(3):1287-1297.

Regulation of the biochemical function of motif VI of HCV NTPase/helicase by the conserved Phe-loop
Hartjen P, Medom B, Reinholz M, Borowski P, Baier A
BIOCHIMIE. 2009;91(2):252-60.

Letzte Aktualisierung aus dem FIS: 09.08.2020 - 00:42 Uhr